Recordati Industria Chimica e Farmaceutica S.p.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 607.82 million compared to EUR 551.36 million a year ago. Net income was EUR 123.6 million compared to EUR 123.95 million a year ago.

Basic earnings per share from continuing operations was EUR 0.599 compared to EUR 0.603 a year ago. Diluted earnings per share from continuing operations was EUR 0.591 compared to EUR 0.593 a year ago.